Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

During the Trading Day
5.14 +0.05 / +0.98%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.11 -0.0273 / -0.53%
 
Volume: 1.0K
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close5.09
Today’s open5.00
Day’s range4.99 - 5.20
Volume34,232
Average volume (3 months)172,077
Market cap$120.0M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+72.30%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc+0.06+2.38%
GTXIGTX Inc+0.00+0.23%
CERUCerulean Pharma Inc+0.01+0.24%
AKAOAchaogen Inc+0.04+0.57%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer, Treasurer &
Senior VP
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers